Efficacy, drug sustainability, and safety of ustekinumab treatment in Crohn’s disease patients over three years
Long-term data on ustekinumab in real-life Crohn’s disease patients are still missing, though randomized controlled trials demonstrated it as a favorable therapeutic option. We aimed to evaluate ustekinumab's clinical efficacy, drug sustainability, and safety in a prospective, nationwide, multi...
Elmentve itt :
| Szerzők: | |
|---|---|
| Dokumentumtípus: | Cikk |
| Megjelent: |
2024
|
| Sorozat: | SCIENTIFIC REPORTS
14 No. 1 |
| Tárgyszavak: | |
| doi: | 10.1038/s41598-024-65987-1 |
| mtmt: | 35077701 |
| Online Access: | http://publicatio.bibl.u-szeged.hu/34398 |